Thiopalmitoylated Peptides from the Peripheral Nervous System Myelin P0 Protein: Synthesis, Characterization, and Neuritogenic Properties

2010 ◽  
Vol 21 (8) ◽  
pp. 1439-1447 ◽  
Author(s):  
Wissam Beaino ◽  
Elisabeth Trifilieff
Keyword(s):  
Nervous System ◽  
Protein Synthesis ◽  
Peripheral Nervous System ◽  
P0 Protein ◽  
Peripheral Nervous System Myelin

Guillain-Barré Syndrome in Children

1986 ◽  
Vol 8 (3) ◽  
pp. 69-74
Author(s):  
Owen B. Evans
Keyword(s):  
Nervous System ◽  
Peripheral Nervous System ◽  
Laboratory Tests ◽  
Routine Laboratory ◽  
Laboratory Studies ◽  
Intensive Care Therapy ◽  
Autoimmune Attack ◽  
Peripheral Nervous System Myelin ◽  
Progressive Weakness ◽  
Careful History

The Guillain-Barré syndrome is an acquired, monophasic illness of the peripheral nervous system. The etiology is an autoimmune attack directed against peripheral nervous system myelin, although the exact mechanism of the immunologic injury is unknown. The major clinical features are rapidly progressive weakness and hyporeflexia, and the most serious complications during the acute phase of the disease are respiratory failure and autonomic cardiovascular disturbances. A careful history, physical examination, and routine laboratory tests are necessary to make a clinical diagnosis and to exclude other disorders that cause acute weakness. Results of laboratory studies that aid in the diagnosis, CSF protein and electrodiagnostic studies, are usually normal during the first week of the illness. The prognosis for children with Guillian-Barré syndrome is excellent for full recovery using modern intensive care therapy for respiratory support and management of other complications.

Sign in / Sign up

Export Citation Format

Share Document